Sexually 0 8 0 8 O
active 9 15 9 15 O
women 16 21 16 21 B-gender
of 22 24 22 24 O
child 25 30 25 30 O
- 30 31 30 31 O
bearing 31 38 31 38 O
potential 39 48 39 48 O

Subject 0 7 49 56 O
who 8 11 57 60 O
have 12 16 61 65 O
received 17 25 66 74 O
ferumoxytol 26 37 75 86 B-treatment
within 38 44 87 93 O
3 45 46 94 95 B-upper_bound
weeks 47 52 96 101 I-upper_bound
of 53 55 102 104 O
study 56 61 105 110 O
entry 62 67 111 116 O

Subjects 0 8 117 125 O
must 9 13 126 130 O
be 14 16 131 133 O
enrolled 17 25 134 142 O
before 26 32 143 149 O
starting 33 41 150 158 O
chemoradiation 42 56 159 173 B-treatment
, 56 57 173 174 O
either 58 64 175 181 O
pre 65 68 182 185 B-treatment
-or 69 72 186 189 I-treatment
post 73 77 190 194 I-treatment
- 77 78 194 195 I-treatment
surgery 78 85 195 202 I-treatment

Subjects 0 8 203 211 O
must 9 13 212 216 O
have 14 18 217 221 O
a 19 20 222 223 O
known 21 26 224 229 O
or 27 29 230 232 O
presumed 30 38 233 241 O
radiological 39 51 242 254 O
diagnosis 52 61 255 264 O
of 62 64 265 267 O
glioblastoma 65 77 268 280 B-cancer
( 78 79 281 282 I-cancer
GBM 79 82 282 285 I-cancer
) 82 83 285 286 I-cancer

Subjects 0 8 287 295 O
who 9 12 296 299 O
have 13 17 300 304 O
a 18 19 305 306 O
contraindication 20 36 307 323 O
for 37 40 324 327 O
3 41 42 328 329 B-treatment
tesla 43 48 330 335 I-treatment
( 49 50 336 337 I-treatment
T 50 51 337 338 I-treatment
) 51 52 338 339 I-treatment
MRI 53 56 340 343 I-treatment

Subjects 0 8 344 352 O
with 9 13 353 357 O
clinically 14 24 358 368 O
significant 25 36 369 380 O
signs 37 42 381 386 O
of 43 45 387 389 O
uncal 46 51 390 395 B-chronic_disease
herniation 52 62 396 406 I-chronic_disease
, 62 63 406 407 O
such 64 68 408 412 O
as 69 71 413 415 O
acute 72 77 416 421 O
pupillary 78 87 422 431 O
enlargement 88 99 432 443 O
, 99 100 443 444 O
rapidly 101 108 445 452 O
developing 109 119 453 463 O
motor 120 125 464 469 O
changes 126 133 470 477 O
( 134 135 478 479 O
over 135 139 479 483 O
hours 140 145 484 489 O
) 145 146 489 490 O
, 146 147 490 491 O
or 148 150 492 494 O
rapidly 151 158 495 502 O
decreasing 159 169 503 513 O
level 170 175 514 519 O
of 176 178 520 522 O
consciousness 179 192 523 536 O

Subjects 0 8 537 545 O
with 9 13 546 550 O
known 14 19 551 556 O
allergic 20 28 557 565 O
or 29 31 566 568 O
hypersensitivity 32 48 569 585 O
reactions 49 58 586 595 O
to 59 61 596 598 O
parenteral 62 72 599 609 B-allergy_name
iron 73 77 610 614 I-allergy_name
, 77 78 614 615 O
parenteral 79 89 616 626 B-allergy_name
dextran 90 97 627 634 I-allergy_name
, 97 98 634 635 O
parenteral 99 109 636 646 B-allergy_name
iron 110 114 647 651 I-allergy_name
- 114 115 651 652 I-allergy_name
dextran 115 122 652 659 I-allergy_name
, 122 123 659 660 O
or 124 126 661 663 O
parenteral 127 137 664 674 B-allergy_name
iron 138 142 675 679 I-allergy_name
- 142 143 679 680 I-allergy_name
polysaccharide 143 157 680 694 I-allergy_name
preparations 158 170 695 707 I-allergy_name

Subjects 0 8 708 716 O
with 9 13 717 721 O
known 14 19 722 727 O
iron 20 24 728 732 O
overload 25 33 733 741 O
( 34 35 742 743 O
genetic 35 42 743 750 O
hemochromatosis 43 58 751 766 B-chronic_disease
) 58 59 766 767 O

Subjects 0 8 768 776 O
with 9 13 777 781 O
three 14 19 782 787 B-lower_bound
or 20 22 788 790 O
more 23 27 791 795 O
drug 28 32 796 800 O
allergies 33 42 801 810 O
from 43 47 811 815 O
separate 48 56 816 824 O
drug 57 61 825 829 O
classes 62 69 830 837 O

for 0 3 838 841 O
presumed 4 12 842 850 O
diagnosis 13 22 851 860 O
of 23 25 861 863 O
GBM 26 29 864 867 B-cancer
, 29 30 867 868 O
histological 31 43 869 881 O
confirmation 44 56 882 894 O
of 57 59 895 897 O
GBM 60 63 898 901 O
must 64 68 902 906 O
be 69 71 907 909 O
completed 72 81 910 919 O
within 82 88 920 926 O
12 89 91 927 929 B-upper_bound
weeks 92 97 930 935 I-upper_bound
of 98 100 936 938 O
enrollment 101 111 939 949 O

in 0 2 950 952 O
subjects 3 11 953 961 O
with 12 16 962 966 O
a 17 18 967 968 O
family 19 25 969 975 O
history 26 33 976 983 O
of 34 36 984 986 O
hemochromatosis 37 52 987 1002 B-chronic_disease
, 52 53 1002 1003 O
hemochromatosis 54 69 1004 1019 O
must 70 74 1020 1024 O
be 75 77 1025 1027 O
ruled 78 83 1028 1033 O
out 84 87 1034 1037 O
prior 88 93 1038 1043 O
to 94 96 1044 1046 O
study 97 102 1047 1052 O
entry 103 108 1053 1058 O
with 109 113 1059 1063 O
normal 114 120 1064 1070 O
values 121 127 1071 1077 O
of 128 130 1078 1080 O
the 131 134 1081 1084 O
following 135 144 1085 1094 O
blood 145 150 1095 1100 O
tests 151 156 1101 1106 O

men 0 3 1107 1110 B-gender

metal 0 5 1111 1116 O
in 6 8 1117 1119 O
their 9 14 1120 1125 O
bodies 15 21 1126 1132 O
( 22 23 1133 1134 O
a 23 24 1134 1135 O
cardiac 25 32 1136 1143 B-treatment
pacemaker 33 42 1144 1153 I-treatment
or 43 45 1154 1156 O
other 46 51 1157 1162 O
incompatible 52 64 1163 1175 O
device 65 71 1176 1182 O
) 71 72 1182 1183 O
, 72 73 1183 1184 O
are 74 77 1185 1188 O
severely 78 86 1189 1197 O
agitated 87 95 1198 1206 O
, 95 96 1206 1207 O
or 97 99 1208 1210 O
have 100 104 1211 1215 O
an 105 107 1216 1218 O
allergy 108 115 1219 1226 O
to 116 118 1227 1229 O
gadolinium 119 129 1230 1240 B-allergy_name
containing 130 140 1241 1251 I-allergy_name
contrast 141 149 1252 1260 I-allergy_name
material 150 158 1261 1269 I-allergy_name

must 0 4 1270 1274 O
agree 5 10 1275 1280 B-contraception_consent
to 11 13 1281 1283 I-contraception_consent
use 14 17 1284 1287 I-contraception_consent
adequate 18 26 1288 1296 I-contraception_consent
contraception 27 40 1297 1310 I-contraception_consent
( 41 42 1311 1312 O
hormonal 42 50 1312 1320 B-contraception_consent
or 51 53 1321 1323 O
barrier 54 61 1324 1331 B-contraception_consent
method 62 68 1332 1338 I-contraception_consent
of 69 71 1339 1341 I-contraception_consent
birth 72 77 1342 1347 I-contraception_consent
control 78 85 1348 1355 I-contraception_consent
; 85 86 1355 1356 O
surgical 87 95 1357 1365 B-treatment
intervention 96 108 1366 1378 I-treatment
i.e. 109 113 1379 1383 O
tubal 114 119 1384 1389 B-contraception_consent
ligation 120 128 1390 1398 I-contraception_consent
or 129 131 1399 1401 O
vasectomy 132 141 1402 1411 B-contraception_consent
; 141 142 1411 1412 O
post 143 147 1413 1417 O
- 147 148 1417 1418 O
menopausal 148 158 1418 1428 O
> 159 160 1429 1430 O
6 161 162 1431 1432 B-upper_bound
months 163 169 1433 1439 I-upper_bound
or 170 172 1440 1442 O
abstinence 173 183 1443 1453 B-contraception_consent
) 183 184 1453 1454 O
for 185 188 1455 1458 O
at 189 191 1459 1461 O
least 192 197 1462 1467 O
two 198 201 1468 1471 B-lower_bound
months 202 208 1472 1478 I-lower_bound
after 209 214 1479 1484 I-lower_bound
each 215 219 1485 1489 O
cycle 220 225 1490 1495 O
of 226 228 1496 1498 O
the 229 232 1499 1502 O
study 233 238 1503 1508 O

pregnant 0 8 1509 1517 B-pregnancy

transferrin 0 11 1518 1529 B-treatment
saturation 12 22 1530 1540 I-treatment
( 23 24 1541 1542 I-treatment
TS 24 26 1542 1544 I-treatment
) 26 27 1544 1545 I-treatment
test 28 32 1546 1550 I-treatment
and 33 36 1551 1554 O
serum 37 42 1555 1560 B-treatment
ferritin 43 51 1561 1569 I-treatment
( 52 53 1570 1571 I-treatment
SF 53 55 1571 1573 I-treatment
) 55 56 1573 1574 I-treatment
test 57 61 1575 1579 I-treatment

who 0 3 1580 1583 O
suspect 4 11 1584 1591 O
they 12 16 1592 1596 O
might 17 22 1597 1602 O
be 23 25 1603 1605 O
pregnant 26 34 1606 1614 B-pregnancy

